Archives

by in
Entry Author Date Location
Cystic Fibrosis Drug Developer N30 Pharmaceuticals Raises $30M 11/20/14 Boulder/Denver
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Vertex Stock Up 40 Percent After Cystic Fibrosis Trial Results 06/24/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
GenePeeks Takes on Preconception Testing With “Digital Babies” 06/18/14 Boston
Roundup: New Funds at Wisegate, Savara, Besomebody, & Dallas startups 06/17/14 Texas
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
Vertex Sells Hep C Drug Royalty Rights to Janssen for $152M 11/20/13 Boston
Flagship’s Pronutria Emerges to Make Medicines and Medical Foods 10/22/13 Boston
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
San Diego’s Carolus Therapeutics Taps Advocate Group for R&D Support 08/27/13 San Diego
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
New Data Could Open Vertex’s CF Drug to 400 More Patients 07/29/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
PTC Therapeutics IPO Raises $125M Despite Checkered Past 06/20/13 New York
The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 06/03/13 National
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
Will $28M in Debt Financing Push Good Start Genetics to Big Finish? 05/08/13 Boston
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
Can Biotech Learn From the TV Production Market? 04/26/13 National
Vertex Pharmaceuticals Booms on Cystic Fibrosis Combo Drug Study 04/18/13 Boston
InVitae, Led by Randy Scott, Goes ‘All-in’ For Genomic Diagnostics 01/18/13 San Francisco
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Page 1 of 4 next page »